Stock Earnings

Question 1

10X Genomics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、10X Genomics Incの総資産は$918で、純lossは$-182です。

Question 2

TXGの主要な財務比率は何ですか？

Accepted Answer

10X Genomics Incの流動比率は4.41、純利益率は-29.83、1株当たり売上高は$5.06です。

Question 3

10X Genomics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

10X Genomics Inc largest revenue segment is Total Instruments, at a revenue of 40,128,000 in the most earnings release.For geography, Europe, Middle East and Africa is the primary market for 10X Genomics Inc, at a revenue of 159,762,000.

Question 4

10X Genomics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、10X Genomics Incの純lossは$-182です。

Question 5

10X Genomics Incに負債はありますか？

Accepted Answer

yes、10X Genomics Incの負債は208です。

Question 6

10X Genomics Incの発行済株式数は何株ですか？

Accepted Answer

10X Genomics Incの総発行済株式数は122.29株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	641	610	618	516	490	298
Revenue Growth (YoY)	2%	-1%	20%	5%	64%	22%
Cost of Revenue	199	196	209	120	74	58
Gross Profit	442	414	409	396	416	240
Selling, General & Admin	330	343	336	298	257	199
Research & Development	245	263	268	265	211	570
Operating Expenses	576	607	604	564	468	771
Other Non Operating Income (Expenses)	1	-1	1	0	0	1
Pretax Income	-73	-177	-248	-162	-53	-534
Income Tax Expense	3	4	6	4	4	8
Net Income	-76	-182	-255	-166	-58	-542
Net Income Growth	-57.99%	-28.99%	54%	186%	-89%	1,648%
Shares Outstanding (Diluted)	125.5	120.45	117.16	113.9	110.3	101.2
Shares Change (YoY)	4%	3%	3%	3%	9%	5%
EPS (Diluted)	-0.62	-1.51	-2.17	-1.46	-0.53	-5.37
EPS Growth	-59%	-30%	49%	175%	-90%	1,578%
Free Cash Flow	81	-6	-64	-165	-122	-256
Free Cash Flow Per Share	0.64	-0.04	-0.54	-1.44	-1.1	-2.52
Gross Margin	68.95%	67.86%	66.18%	76.74%	84.89%	80.53%
Operating Margin	-20.9%	-31.47%	-31.39%	-32.36%	-10.61%	-178.18%
Profit Margin	-11.85%	-29.83%	-41.26%	-32.17%	-11.83%	-181.87%
Free Cash Flow Margin	12.63%	-0.98%	-10.35%	-31.97%	-24.89%	-85.9%
EBITDA	-106	-157	-159	-142	-31	-517
EBITDA Margin	-16.53%	-25.73%	-25.72%	-27.51%	-6.32%	-173.48%
D&A For EBITDA	28	35	35	25	21	14
EBIT	-134	-192	-194	-167	-52	-531
EBIT Margin	-20.9%	-31.47%	-31.39%	-32.36%	-10.61%	-178.18%
Effective Tax Rate	-4.1%	-2.25%	-2.41%	-2.46%	-7.54%	-1.49%

10X Genomics Inc (TXG) Price

TXG Stock Price Chart

TXG Income

Follow-Up Questions